AstraZeneca Provides $49.6 Million In Prescription Savings To North Carolina Residents In 2010

Main Category: Pharma Industry / Biotech Industry
Article Date: 02 Feb 2011 - 8:00 PDT

Current ratings for:
'AstraZeneca Provides $49.6 Million In Prescription Savings To North Carolina Residents In 2010'

Patient / Public:not yet rated

Healthcare Prof:not yet rated


AstraZeneca (NYSE:AZN) announced today that it provided $49.6 million in savings last year to 33,977 patients in North Carolina who participate in its AZ&Me prescription savings programs. North Carolina residents filled a total of 277,122 prescriptions under these programs that provide AstraZeneca medicines at no cost to eligible patients.

"While the economy appears to be getting stronger, we are still seeing record numbers of patients in our prescription savings programs and they are staying in the programs longer," said Rich Fante, President AstraZeneca U.S. & Regional VP North America.

Nationally, AstraZeneca helped 545,937 patients fill more than 4.1 million prescriptions for $947 million in savings through its AZ&Me prescription savings programs in 2010.

AstraZeneca provides free medicines to patients through its AZ&Me prescription savings programs in three ways:

- Individuals: AstraZeneca provides free medicines to qualifying individuals without prescription drug coverage who make up to $30,000 per year and families of four with $60,000 annual household income.

- Part D beneficiaries: AstraZeneca provides free medicines for qualifying Medicare Part D patients who make up to $30,000 per year or couples who make up to $40,000 per year. Medicare Part D patients can have their filled prescription mailed to their home or physician's office.

- Healthcare facilities: AstraZeneca provides free medicines to qualifying non-profit organizations, such as disproportionate share hospitals, community health centers and community free clinics. This program connects patients to the medicines they need at the same time and place they receive their treatment.

Source:
AstraZeneca

Article adapted by Medical News Today from original press release.
Visit our pharma industry / biotech industry section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
AstraZeneca. "AstraZeneca Provides $49.6 Million In Prescription Savings To North Carolina Residents In 2010." Medical News Today. MediLexicon, Intl., 2 Feb. 2011. Web.
16 May. 2012. <http://www.medicalnewstoday.com/releases/215399.php>

APA
AstraZeneca. (2011, February 2). "AstraZeneca Provides $49.6 Million In Prescription Savings To North Carolina Residents In 2010." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/215399.php.

Please note: If no author information is provided, the source is cited instead.



Add Your Opinion On This Article

'AstraZeneca Provides $49.6 Million In Prescription Savings To North Carolina Residents In 2010'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Your Name:*
E-mail Address:*
Your Opinion Title:*
Opinion:*
This is to help prevent SPAM submissions. Please enter the words exactly as they appear, including capital letters and punctuation.*

* Fields marked with a * need to be filled in before you hit the submit button.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.


Pharma Industry / Biotech Industry

Most Popular Articles



Follow Our Pharma Industry News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Pharma Industry / Biotech Industry Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »